Replies to post #420301 on Elite Pharmaceuticals Inc (ELTP)

[rack186]

Anything of value will go to Mikah first, which means you won't hear a peep from the " Rat "
Order of importance -
1.)Nasrat
2.)Mikah
3.)Share holders,

[Just give me $1.50]

He ALREADY conducted BE studies on 2 of those drugs last year.

Like a said a dozen times already, the BE studies FAILED.

Imagine what Nasrat might say during the conference call about future potential B/E studies with a few of these drugs

25 High-Valued Drugs Losing Patent Protection in 2025

[jour_trader]

He doesn't divulge what drugs are in formulary stage. He has hinted one being the last CNS (likely Concerta), but this has been in development stage for years.

Lots of funding for R&D, but not much to show for it. I'd like to see a couple products have positive BE this year.